A Study of Brexanolone for Acute Respiratory Distress Syndrome Due to COVID-19
Status:
Terminated
Trial end date:
2021-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of brexanolone in
participants on ventilator support for acute respiratory distress syndrome (ARDS) due to
COVID-19.